Hikma Pharmaceutical | Lånekapital



Loan Capital Endring Dato
Almirall EUR 351.76M 538K 2024-06
AstraZeneca USD 27.73B 2.29B 2024-12
Bayer EUR 34.55B 2.12B 2024-12
Fresenius EUR 13.28B 1.81B 2024-12
Galapagos EUR 8.24M 1000K 2024-12
Genmab DKK 937M 41M 2024-12
GlaxoSmithKline GBP 14.64B 1.39B 2024-12
GRIFOLS EUR 8.68B 155.99M 2024-12
Hikma Pharmaceutical USD 1.06B 31M 2024-06
Lonza CHF 4.24B 602M 2024-12
Merck EUR 7.88B 62M 2024-09
Orion EUR 297.2M 69.7M 2024-12
Recordati EUR 1.26B 87.43M 2024-09
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 12.5B 1.84B 2024-06
UCB EUR 2.82B 166M 2024-12



Hikma Pharmaceutical Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.